Clinical Trials Focus Valis Bioscience specializes in psychiatric and neurological clinical trials with experience across schizophrenia, depression, anxiety, bipolar disorder, rare and orphan diseases, Parkinson’s, Alzheimer’s, and psychedelic-assisted research, indicating strong cross-indication expertise for sponsors in CNS and emerging therapies.

23 CFR 11 Integration The company is an early adopter of 21 CFR Part 11 compliant video recording for trial monitoring and assessment, presenting a compelling value proposition for sponsors needing compliant data capture, remote monitoring, and centralized review capabilities in complex studies.

End-to-End Services Valis combines scientific and clinical consulting with rater training, data validation, scale development, psychometrics, protocol review, and licensing, enabling a single vendor to support trial design through execution, which can streamline procurement for sponsors.

Proprietary and Licensed Tools Product offerings include video and audio recording systems, ML-backed transcription, eCOA and PRO technologies, LMS, API access to Pearson assessments, and centralized review, creating multiple upsell paths for biopharma customers pursuing digital data capture and measurement.

Strategic Partnerships With a lean team and revenue in the mid range for CRO-adjacent midsize providers, Valis presents an opportunity for larger CROs or pharma sponsors to partner on niche CNS and psychedelic programs, potentially expanding service scope through collaborations or channel partnerships.